- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Development of NK cell-based cancer immunotherapies through receptor engineering ; volume:21 ; number:4 ; day:5 ; month:3 ; year:2024 ; pages:315-331 ; date:4.2024
Cellular & molecular immunology ; 21, Heft 4 (5.3.2024), 315-331, 4.2024
- Creator
-
Page, Audrey
Chuvin, Nicolas
Valladeau-Guilemond, Jenny
Depil, Stéphane
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41423-024-01145-x
- URN
-
urn:nbn:de:101:1-2406240941305.312970509144
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Page, Audrey
- Chuvin, Nicolas
- Valladeau-Guilemond, Jenny
- Depil, Stéphane
- SpringerLink (Online service)
Other Objects (12)
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Challenges of NK cell-based immunotherapy in the new era
Stem cell-based adipose tissue engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
NK cell-based cancer immunotherapy: from basic biology to clinical development
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Challenges of NK cell-based immunotherapy in the new era
Stem cell-based adipose tissue engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
NK cell-based cancer immunotherapy: from basic biology to clinical development
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Challenges of NK cell-based immunotherapy in the new era
Stem cell-based adipose tissue engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies